Yungjin Plans to Attain Large-Scale Production Capability for Coenzyme Q10

Published: 2005-03-09 06:58:00

Updated: 2005-03-09 06:58:00

In an effort to meet the surging demand for Coenzyme Q10 (CoQ10) in the global marketplace, Yungjin Pharmaceutical has announced of its plan to build a dedicated production plant with an annual output of CoQ10 up to 50 tons.

CoQ10's recognition and use as a potent antioxidant has driven the gl...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK